Investor Accounting Analyst
ValonFull Time
Mid-level (3 to 4 years)
Key technologies and capabilities for this role
Common questions about this position
This is a hybrid position requiring 2-3 in-office days per week and additional on-site presence as needed, with candidates required to reside in the San Diego area and commute to corporate offices.
The role involves financial analysis and reporting such as preparing earnings deliverables and summarizing market insights, serving as a liaison for investors and analysts, monitoring peer performance, and leading operations for investor-facing events.
Strong financial analysis, reporting, communication skills, and a polished professional presence are essential, along with the ability to coordinate cross-functionally and interact with senior leadership, investors, and Wall Street analysts.
Illumina fosters a collaborative environment where every person has the opportunity to make a difference, surrounded by extraordinary people, inspiring leaders, and world-changing projects in genomic technology for health equity.
A strong candidate will have experience in financial analysis, investor relations, event coordination, and peer benchmarking, with excellent communication skills and the ability to manage interactions with senior executives and external stakeholders.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.